AJANTPHARM has declared results for the period ended Jun 2021.
Quarterly Results
[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]
- Sales for period ended Jun 2021 is Rs 748.0 cr compared to Rs 668.0 cr for period ended Jun 2020, a rise of 12.0%
- Operating Profits reported at Rs 220.0 cr for period ended Jun 2021 vis-vis 223.0 for period ended Jun 2020 .
- Operating Margins contracted -397.1 bps for period ended Jun 2021 vis-vis Jun 2020 .
- The EPS for Jun 2021 was Rs 20.08 compared to Rs 18.4 for previous quarter ended Mar 2021 and Rs 16.93 for Jun 2020
- The stock is trading at Rs 2332 and a market cap of Rs 20178 cr
[/s2If]
Trading Chart
Further analysis and Full Company Research with investing scores is available here: AJANTPHARM